Maternal Dopamine Encodes Affective Signals of Human Infants.
Lior ZeeviMerav IraniCiprian CatanaLisa Feldman BarrettShir AtzilPublished in: Social cognitive and affective neuroscience (2021)
Mothers are highly responsive to their offspring. In non-human mammals, mothers secrete dopamine in the nucleus accumbens (NAcc) in response to their pups. Yet, it is still unknown which aspect of the offspring-behavior elicits dopaminergic responses in mothers. Here we tested whether infants' affective signals elicit dopaminergic responses in the NAcc of human mothers. First, we conducted a behavioral analysis on videos of infants' free-play, and quantified the affective signals infants spontaneously communicated. Then, we presented the same videos to mothers during a magnetic resonance-positron emission tomography (MR-PET) scan. We traced the binding of [11C]raclopride to free D2/3-type receptors to assess maternal dopaminergic responses during the infant-videos. When mothers observed videos with many infant-signals during the scan, they had less [11C]raclopride binding in the right NAcc. Less [11C]raclopride binding indicates that less D2/3 receptors were free, possibly due to increased endogenous dopamine responses to infants' affective signals. We conclude that NAcc D2/3 receptors are involved in maternal responsiveness to affective signals of human infants. D2/3 receptors have been associated with maternal responsiveness in nonhuman animals. This evidence supports a similar mechanism in humans, and specifies infant-behaviors that activate the maternal dopaminergic system, with implications for social neuroscience, development and psychopathology.
Keyphrases
- endothelial cells
- computed tomography
- positron emission tomography
- magnetic resonance
- bipolar disorder
- birth weight
- induced pluripotent stem cells
- pregnancy outcomes
- pluripotent stem cells
- healthcare
- high fat diet
- type diabetes
- skeletal muscle
- pregnant women
- pet imaging
- magnetic resonance imaging
- mental health
- insulin resistance
- transcription factor
- binding protein
- gestational age
- cancer therapy